Skip to main content
AI Market Summary
Loading market intelligence...

Provention Bio Inc (PRVB) Stock Forecast 2025 - AI Price Prediction & Analysis


Provention Bio Inc (PRVB) AI Stock Price Forecast & Investment Analysis

Provention Bio Inc Stock Price Chart and Technical Analysis

Loading Provention Bio Inc interactive price chart and technical analysis...

Provention Bio Inc (PRVB) - Comprehensive Stock Analysis & Investment Research

Deep dive into Provention Bio Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Provention Bio Inc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Provention Bio Inc: Provention Bio Inc operates in the Manufacturing sector, establishing it as a mid-cap growth opportunity.

Provention Bio Inc (Stock Symbol: PRVB) is a leading company in the Manufacturing sector , specifically operating within the Medicinal and Botanical Manufacturing industry.

The organization employs approximately 82 professionals worldwide and operates under the strategic leadership of CEO Ashleigh Palmer.

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Provention Bio Inc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Provention Bio Inc: With $70M in annual revenue and -160.5% net margin, the company demonstrates developing profitability.

Annual Revenue: $70 million generating a -160.5% net profit margin .

Market Capitalization: $2190 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -74.8% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Provention Bio Inc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Provention Bio Inc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Provention Bio Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Provention Bio Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Provention Bio Inc: Market positioning analysis based on available financial and operational metrics.

Provention Bio Inc strategically competes in the highly dynamic Medicinal and Botanical Manufacturing marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company maintains a healthy 18.2% gross margin, indicating strong pricing power and operational efficiency.

Provention Bio Inc (PRVB) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Provention Bio Inc stock analysis.

Loading Provention Bio Inc comprehensive fundamental analysis and insider trading data...

Deep dive into Provention Bio Inc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Provention Bio Inc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Provention Bio Inc: With a P/E ratio of -2.47, the market sees the stock as potentially undervalued.

P/E Ratio -2.47x
P/B Ratio 17.97x
Market Cap $2190M
EPS $-1.52
Book Value/Share $1.39
Revenue/Share $0.15
FCF/Share $-1.23
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Provention Bio Inc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Provention Bio Inc: An ROE of -74.8% indicates room for improvement in shareholder value creation.

ROE -74.8%
ROA -61.8%
ROIC -74.6%
Gross Margin 18.2%
Operating Margin -181.1%
Net Margin -160.5%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Provention Bio Inc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Provention Bio Inc: A current ratio of 3.39 indicates strong liquidity.

Current Ratio 3.39x
Quick Ratio 3.14x
D/E Ratio 0.01x
Financial Leverage 1.30x
Working Capital $110M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Provention Bio Inc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Provention Bio Inc: Free cash flow of $-95M indicates cash challenges that need attention.

Operating Cash Flow $-94M
Free Cash Flow $-95M
Capital Spending $-1M
CapEx/Sales 68.9%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Provention Bio Inc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Provention Bio Inc: An asset turnover of 0.01x suggests room for improvement in asset utilization.

Asset Turnover 0.01x
Fixed Assets Turnover 0.9x
Understanding Financial Statement Data

What these metrics mean: Key figures from Provention Bio Inc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Provention Bio Inc: With annual revenue of $70M, Provention Bio Inc represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $70M
Operating Income $-128M
Net Income $-113M
R&D Expense $76M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 75%
Cash & Short-term Investments 69%
Total Liabilities 23%
Dividend & Shareholder Information
Shares Outstanding 88M
Growth Metrics (YoY)
EPS Growth -6.1%

Latest Provention Bio Inc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Provention Bio Inc (PRVB) stock price and investment outlook.

, source: NJBIZ

Following Sanofi‘s $35 million equity investment last month, the global health care company will acquire Red Bank-based Provention Bio Inc. for $25 per share, representing an equity value of ...

, source: Insider Monkey

Tourlite Capital Management, an investment management company, released its fourth-quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, Tourlite Fund Founder ...

Provention Bio Inc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Provention Bio Inc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Provention Bio Inc Stock Forecast

How accurate are Provention Bio Inc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for PRVB predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Provention Bio Inc stock price forecasts?

Our analysis considers Provention Bio Inc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Provention Bio Inc a good investment in 2025?

Based on our AI analysis, Provention Bio Inc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Provention Bio Inc forecasts updated?

Provention Bio Inc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Provention Bio Inc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Provention Bio Inc stock.

My Portfolio

Investment Dashboard

Loading your portfolio...